iX Biopharma (SGX:42C) YoY EPS Growth

: -300.00% (As of Dec. 2022)

View and export this data going back to 2015. Start your Free Trial

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. iX Biopharma's YoY EPS Growth for the quarter that ended in Dec. 2022 was -300.00%.

iX Biopharma's Earnings per Share (Diluted) for the six months ended in Dec. 2022 was S$-0.01.

iX Biopharma YoY EPS Growth Historical Data

The historical data trend for iX Biopharma's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iX Biopharma Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

YoY EPS Growth

-91.67

78.26

-220.00

25.00

50.00

iX Biopharma Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22
YoY EPS Growth														55.56	-14.29	225.00	-37.50	-300.00

iX Biopharma YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

iX Biopharma's YoY EPS Growth for the fiscal year that ended in Jun. 2022 is calculated as:

	YoY EPS Growth (A: Jun. 2022 )
=	(Earnings per Share (Diluted) (A: Jun. 2022 )	-	Earnings per Share (Diluted) (A: Jun. 2021 ))	/	\| Earnings per Share (Diluted) (A: Jun. 2021 ) \|
=	(-0.006	-	-0.012)	/	\| -0.012 \|
=	50.00 %

iX Biopharma's YoY EPS Growth for the quarter that ended in Dec. 2022 is calculated as:

	YoY EPS Growth (Q: Dec. 2022 )
=	(Earnings per Share (Diluted) (Q: Dec. 2022 )	-	Earnings per Share (Diluted) (Q: Dec. 2021 ))	/	\| Earnings per Share (Diluted) (Q: Dec. 2021 )) \|
=	(-0.01	-	0.005)	/	\| 0.005 \|
=	-300.00 %

iX Biopharma YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of iX Biopharma's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

iX Biopharma (SGX:42C) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » iX Biopharma Ltd (SGX:42C) » Definitions » YoY EPS Growth

Traded in Other Exchanges

N/A

Address

1 Kim Seng Promenade, No. 14-01, Great World City East Lobby, Singapore, SGP, 237994

Website

https://www.ixbiopharma.com

iX Biopharma Ltd is a Singapore-based specialty pharmaceutical and nutraceutical company focused on the development, manufacture, and commercialization of therapies for the treatment of acute and breakthrough pain, and other health conditions. Its products under development are Wafermine and BnoX for pain management, Wafesil for erectile dysfunction, WafeRest for improved sleep quality, and others. Its business segments are Specialty Pharmaceutical and Nutraceutical business segments. The firm's business segments operate in United States of America, Singapore, Australia, and China, of which the majority of the revenue comes from United States of America.

iX Biopharma (SGX:42C) Headlines

No Headlines